NCT05418712View on ClinicalTrials.gov

A Microneurography (MNG) Study of VX-150 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 16, 2022

Primary Completion Date

September 14, 2022

Study Completion Date

September 23, 2022

Conditions
Pain
Interventions
DRUG

Placebo

Placebo matched to VX-150 for oral administration.

DRUG

VX-150

Solution or Suspension for oral administration.

Trial Locations (1)

Unknown

MAC Clinical Research, Manchester

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY